About this trial
The aim of the study is to clarify whether the perioperative release of the cardiac biomarkers troponin I, troponin T and CK-MB consistently correlate with visualizable myocardial damage, and to what extent these biomarkers are comparable by means of their kinetics and dynamics.
Due to the uncertainty regarding the validity of cardiac biomarkers in the diagnosis of myocardial infarction, the answer to these questions could have a considerable influence on internationally valid guidelines and definitions. International studies, especially in the field of coronary surgery and coronary artery disease treatment refer to these definitions, in particular, the adequate treatment of affected patients is directly dependent on them.
Eligibility criteria
Qualifiers
Indication for isolated aortic or mitral valve surgery
Written informed consent
Age ≥ 18 years
Disqualifiers
Presence of coronary artery disease (excluded within the last 6 months)
Allergy to gadolinium
Cochlear implant
Deep brain stimulation
Trial design
Treatments tested in this trial
- Not listed